Involvement of the peroxisome proliferator-activated receptor (PPAR) alpha in vascular response of endocannabinoids in the bovine ophthalmic artery

European Journal of Pharmacology

Volumn 683, Issue 1-3, 2012, Pages 197-203

  Romano, Maria Rosaria ^a   Lograno, Marcello Diego ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Anandamide; Nitric oxide; Ophthalmic artery; Palmitoylethanolamide; Peroxisome proliferators activated receptor alpha

Indexed keywords

ANANDAMIDE; CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; NITRIC OXIDE SYNTHASE; PALMIDROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL REACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; COW; MYOGRAPHY; NONHUMAN; OPHTHALMIC ARTERY; PRIORITY JOURNAL; VASODILATATION;

ANIMALS; ARACHIDONIC ACIDS; CANNABINOID RECEPTOR MODULATORS; CATTLE; ENDOCANNABINOIDS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; ETHANOLAMINES; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MYOGRAPHY; NITRIC OXIDE SYNTHASE; OPHTHALMIC ARTERY; OSMOLAR CONCENTRATION; PALMITIC ACIDS; POLYUNSATURATED ALKAMIDES; PPAR ALPHA; PPAR GAMMA; RECEPTOR, CANNABINOID, CB1; SEROTONIN; SIGNAL TRANSDUCTION; TIME FACTORS; VASODILATION;

EID: 84860444108     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.02.049     Document Type: Article

References (23)

1. M. Bouaboula, S. Hilairet, J. Marchard, L. Fajas, G. Le Fur, and P. Casellas Anandamide induced PPARγ transcriptional activation and 3T3-L1 pre-adipocyte differentiation Eur. J. Pharmacol. 517 2005 174 181
2. H. Cadas, E. di Tomaso, and D. Piomelli Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain J. Neurosci. 17 1997 1226 1242
3. W.A. Devane, L. Hanuš, A. Breuer, R.G. Pertwee, L.A. Stevenson, G. Griffin, D. Gibson, A. Mandelbaum, A. Etinger, and R. Mechoulam Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science 18 1992 1946 1949
4. P. Ferrè The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity Diabetes 53 2004 S43 S50
5. K. Goya, S. Sumitami, X. Xu, T. Kitamura, H. Yamamoto, S. Kurebayaski, H. Saito, H. Kouhara, S. Kasayama, and I. Kawase Peroxisome proliferator-activated receptor alpha agonists increase nitric oxide synthase expression in vascular endothelial cells Arterioscler. Thromb. Vasc. Biol. 24 2004 658 663
6. G. Griffin, Q. Tao, and M.E. Abood Cloning and pharmacological characterization of the rat CB(2) cannabinoid receptor J. Pharmacol. Exp. Ther. 292 2000 886 894
7. W.-S.V. Ho, D.A. Barrett, and M.D. Randall 'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors Br. J. Pharmacol. 155 2008 837 846
8. Y. Irukayama-Tomobe, T. Miyauchi, Y. Kasuya, S. Sakai, K. Goto, and I. Yamaguchi Activation of peroxisome proliferator-activated receptor-alpha decreases endothelin-1-induced p38 mitogen-activated protein kinase activation in cardiomyocytes J. Cardiovasc. Pharmacol. 44 2004 S358 S361
9. K.R. Kozak, R.A. Gupta, J.S. Moody, C. Ji, W.E. Boeglin, R.N. DuBois, A.R. Brash, and L.J. Marnett 15-lipoxygenase metabolism of 2- arachidonylglycerol. Generation of a peroxisome proliferator-activated receptor alpha agonist J. Biol. Chem. 277 2002 23278 23286
10. D.M. Lambert, and C.J. Fowler The endocannabinoid system: drug targets, lead compounds and potential therapeutic applications J. Med. Chem. 48 2005 5059 5087
11. J. Lo Verme, J. Fu, G. Astarita, G. La Rana, R. Russo, A. Calignano, and D. Piomelli The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide Mol. Pharmacol. 67 2005 15 19
12. S.E. O'Sullivan Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors Br. J. Pharmacol. 152 2007 576 582
13. S.E. O'Sullivan, D.A. Kendall, and M.D. Randall Vascular effects of delta 9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta Eur. J. Pharmacol. 507 2005 211 221
14. S.E. O'Sullivan, D.A. Kendall, and M.D. Randall Further characterization of the time-dependent vascular effects of Δ9-tetrahydrocannabinol J. Pharmacol. Exp. Ther. 317 2006 428 438
15. S.E. O'Sullivan, D.A. Kendall, and M.D. Randall Time-dependent vascular effects of endocannabinoids mediates by peroxisome proliferator-activated receptor gamma (PPARγ) PPAR Res. 2009 2009 425289 425298
16. S.E. O'Sullivan, Y. Sun, A.J. Bennett, M.D. Randall, and D.A. Kendall Time-dependent vascular actions of cannabidiol in the rat aorta Eur. J. Pharmacol. 612 2009 61 68
17. P. Pacher, S. Batkai, and G. Kunos The endocannabinoid system as an emerging target of pharmacotherapy Pharmacol. Rev. 58 2006 389 462
18. M. Pistis, and M. Melis From surface to nuclear receptors: the endocannabinoid family extends its assets Curr. Med. Chem. 17 2010 1450 1467
19. M.R. Romano, and M.D. Lograno Cannabinoid agonists induce relaxation in the bovine ophthalmic artery: evidences for CB1 receptors, nitric oxide and potassium channels Br. J. Pharmacol. 147 2006 917 925
20. Y. Sun, S.P. Alexander, D.A. Kendall, and A.J. Bennett Cannabinoids and PPARα signalling Biochem. Soc. Trans. 34 2006 1095 1097
21. R.M. Touyz, and E.L. Schiffrin Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications Vasc. Pharmacol. 45 2006 19 28
22. G. Turu, and L. Hunyady Signal transduction of the CB1 cannabinoid receptor J. Mol. Endocrinol. 44 2010 75 85
23. P.M. Zygmunt, J. Petersson, D.A. Andersson, H. Chuang, M. Sorgǎrd, V. Di Marzo, D. Julius, and E.D. Högestätt Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide Nature 400 1999 452 457